Diwakar Davar

This study tests a treatment made from healthy donor gut bacteria (MTP-101-C) for cancer patients who have severe skin or gut side effects from immunotherapy that don't get better with steroids. About 30 participants will receive the therapy to see if it can safely resolve these …

This study tests a drug called tebentafusp in people with a specific genetic type (HLA-A*0201) who have metastatic uveal melanoma, a rare eye cancer that has spread and has not been treated yet. The drug aims to help the immune system attack cancer cells. Researchers will also us…

This study tests whether a transplant of healthy gut bacteria (from donor stool) combined with the immunotherapy drug pembrolizumab can help people with advanced lung cancer that has stopped responding to standard treatments. About 26 participants will receive the bacteria transp…

This study looks at whether people with certain cancers prefer getting their immunotherapy (nivolumab or pembrolizumab) as a shot under the skin or as an IV drip. About 880 patients will try both methods and say which they like better. The goal is to understand patient preference…